GlioGuard
Pre-clinicalWe make glioblastoma a treatable disease Glioblastoma,the disease in numbers Epidemiology 0 Glioblastoma (GBM) affects 3.19 per 100’000 individuals in working age. Following resection and pharmacological therapy, tumor relapses make the average prognosis less than two years. Life expectancy (months) 0 GBM is a malignant brain cancer amongst the most lethal types of cancer. There […]
About
We make glioblastoma a treatable disease Glioblastoma,the disease in numbers Epidemiology 0 Glioblastoma (GBM) affects 3.19 per 100’000 individuals in working age. Following resection and pharmacological therapy, tumor relapses make the average prognosis less than two years. Life expectancy (months) 0 GBM is a malignant brain cancer amongst the most lethal types of cancer. There […]
Company Info
Contact
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile